Mergers & Acquisitions

Share SHARE

Stantec Inc. (STN.TO, STN) said Wednesday that it has signed a letter of intent to buy JBR Environmental Consultants. Based in Salt Lake City, Utah, JBR is a 140-person full-service environmental consulting firm operating in 12 western US locations. The deal is expected to close in May.

Crown Holdings, Inc. (CCK) said Wednesday that it has completed its acquisition of Mivisa Envases, SAU, a Spanish manufacturer of two- and three-piece food cans and ends, from certain investment funds managed by affiliates of The Blackstone Group L.P., N+1 Mercapital and management. In late October,...

French software company Dassault Systemes SA (DASTY.PK) on Wednesday again extended its public tender offer for all shares of U.S.-based Accelrys Inc. (ACCL) to April 28. Dassault Systemes, a provider of 3D design software, in late January offered to pay $12.50 for each Accelrys share in cash. Except...

Google Inc. (GOOGL, GOOG) has signed a renewable energy deal with MidAmerican Energy Holdings Co., the two companies said Tuesday. Under the deal, MidAmerican Energy, a unit of billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK-B, BRK-A, BRKa) will supply up to 407 megawatts of wind-sourced energy...

Stericycle, Inc. (SRCL) said Tuesday that it has acquired PSC Environmental Services, LLC, a portfolio company of Lindsay Goldberg LLC and a provider of environmental and regulated waste management solutions. Subject to various adjustments, the total consideration for the PSC Environmental acquisition...

Allergan Inc. (AGN) confirmed Tuesday that it has received an unsolicited proposal from Canadian drug maker Valeant Pharmaceuticals International Inc. (VRX, VRX.TO) to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares and C$48.30 in cash per share...

Valeanut-Allergan-042214.jpg Canadian drug maker Valeant Pharmaceuticals International Inc. Tuesday announced that it has submitted a merger proposal to acquire Allergan, Inc., which is famous for its wrinkle treatment drug Botox, for C$48.30 in cash and 0.83 Shares of Valeant stock for each Allergan share.

Whiskey maker Beam Inc (BEAM) said the $16 billion acquisition of the company by Japan's Suntory Holdings has received regulatory clearance from the European Commission. Upon completion, each share of Beam common stock will convert into the right to receive $83.50 in cash. The companies now expect...

Cognizant (CTSH) announced it has entered into a definitive agreement to acquire itaas, a digital video solutions company headquartered in Atlanta, Georgia. The terms of the deal were not disclosed. Itaas helps leading cable, telecommunications, and technology companies to deliver a broad range of...

Jacobs Engineering Group Inc. (JEC) Tuesday said it has entered into an agreement to acquire Federal Network Systems or FNS, a subsidiary of Verizon Communications. The terms of the agreement were not disclosed. Closing of the transaction is expected to occur in the summer of 2014. FNS provides...

Canadian drug maker Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) Tuesday announced that it has submitted a merger proposal to the Board of Directors of Allergan, Inc. (AGN), under which each Allergan share would be exchanged for $48.30 in cash and 0.83 shares of Valeant common stock, based...

Eli-Lilly-Acquire-Novartis-Animal-Health-042214.jpg Swiss drug maker Novartis AG (NVS) Tuesday said it has reached a definitive agreement with GlaxoSmithKline Plc. (GSK, GSK.L) to exchange certain assets. Separately, the company announced a definitive agreement with Eli Lilly and Co. (LLY) to divest the Animal Health Division for $5.4 billion, to further focus its portfolio on the innovative pharmaceuticals, eye care and generics.

QinetiQ US Holdings Inc., an indirect subsidiary of QinetiQ Group plc (QQ.L), announced it has entered into a conditional agreement to sell the QinetiQ Group's US Services division (excluding Cyveillance) to The SI Organization, Inc. for an initial cash consideration of US$165 million plus a potential...

Novartis International AG (NVS) announced it has reached a definitive agreement with GlaxoSmithKline plc (GSK.L, GSK) to exchange certain assets. Under the agreement, Novartis will acquire GSK oncology products, and would divest Vaccines (excluding flu) to them. The companies would also create a joint...

Eli Lilly and Co. (LLY) Tuesday announced an agreement to acquire Novartis Animal Health for about $5.4 billion in an all-cash transaction that will strengthen and diversify Lilly's own animal health business, Elanco. When the acquisition is completed, Elanco will be the second-largest animal health...